The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus. Researchers say the Lancet ...

Led by the Oxford Vaccine Group at the University of Oxford, the phase I trial – funded by USAID – was testing two innovative vaccines designed to prevent the malaria parasite from entering ...

A new study is set to test a vaccine looking to protect against a disease caused by two different types of Salmonella bacteria. The Oxford Vaccine Group has launched the BiVISTA study to evaluate ...

Unfortunately, one such experimental vaccine, developed by scientists at the University of Oxford and AstraZeneca, performed dismally in a small Phase 1 clinical trial, according to results published ...

The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine. The UK's vaccine advisory body is set to decide ...

By the beginning of March 2021, three vaccines have been approved for use in the UK - one made by Pfizer/BioNTech, another by Oxford AstraZeneca and a third by Moderna. Now, the team behind one of ...

A method of identifying falsified vaccines without opening the vaccine vial has been developed by researchers at the University of Oxford. The approach analyses the vaccine vial label and its ...

Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...